Showing 861 - 880 results of 105,995 for search '(( a fold decrease ) OR ( 5 ((point decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.82s Refine Results
  1. 861
  2. 862
  3. 863
  4. 864
  5. 865
  6. 866
  7. 867
  8. 868

    VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

    Published 2018
    “…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10<sup>-5</sup>), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10<sup>-5</sup>), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10<sup>-22</sup>), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10<sup>-71</sup>), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10<sup>-28</sup>), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10<sup>-12</sup>), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10<sup>-10</sup>) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10<sup>-17</sup>). …”
  9. 869
  10. 870
  11. 871

    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

    Published 2024
    “…There was a significant decrease in the ratio of pmTOR to mTOR. …”
  12. 872

    Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

    Published 2024
    “…There was also a significant decrease in SMAD and pSMAD in the SIT group. …”
  13. 873
  14. 874
  15. 875

    Blocking of MC1R, MC2R or MC5R causes a decrease in the enucleation ratio of erythrocytes. by Eriko Simamura (720229)

    Published 2015
    “…The enucleation ratio was decreased in the erythroblasts treated with anti-MC1R nAb, anti-MC2R nAb or anti-MC5R nAb. *, <i>P <</i> 0.0001, each point versus control. n = 3; error bars, s.e.m. …”
  16. 876
  17. 877

    Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

    Published 2024
    “…There was also a significant decrease in pPKC alpha in the SIT-I myocardium compared to SIT-N. …”
  18. 878
  19. 879
  20. 880

    At E9.5 Actb<sup>−/−</sup> neural crest cells show a significant decrease of cadherin-11 expression. by Davina Tondeleir (426905)

    Published 2014
    “…<p>(A) Quantification of N-cadherin intensities in Actb<sup>+/+</sup> and Actb<sup>−/−</sup> migratory cells adjacent to the neural tube at E8.5 and E9.5 (left graph, Y-axis: relative intensities) and colocalization of N-cadherin with p75 in migratory cells at E8.5 and E9.5 (right graph, Y-axis: colocalization index on a scale from 0 to 1). …”